Zecyte (Abiraterone) [https://medzpills.com/product/zecyte-abiraterone/] is not typically prescribed for women, as it is primarily indicated for the treatment of advanced prostate cancer in men. Its mechanism of action involves inhibiting androgen production, which is not relevant to female physiology in the same way it is for males. Additionally, the safety and efficacy of Zecyte specifically in women have not been extensively studied. Women who are pregnant, breastfeeding, or planning to become pregnant should avoid Zecyte due to its potential risks to fetal development. Any use of Zecyte in women would require careful consideration and consultation with a healthcare provider, taking into account the individual's medical history and specific circumstances.

Wiem, że mojej babci przepisano ten lek.